Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations

Similar Items

• Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions
  od: Guglielmi, Chiara, i dr.
  Izdano: (2021)
• Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
  od: Metcalfe, K A, i dr.
  Izdano: (2009)
• The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
  od: Paul, Arindam, i dr.
  Izdano: (2014)
• Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
  od: Cipollini, G., i dr.
  Izdano: (1999)
• Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
  od: Lee, Chee Khoon, i dr.
  Izdano: (2019)